Literature DB >> 7490243

Preoperative therapy for soft tissue sarcoma.

F Eilber1, J Eckardt, G Rosen, C Forscher, M Selch, Y S Fu.   

Abstract

Soft tissue sarcomas appear to be an ideal tumor type for delivering preoperative therapy. The rationale for preoperative therapy is that it is delivered to undisturbed tissue planes with well-oxygenated tissue. This is of great benefit for radiation therapy, because with new computed tomography scan treatment planning it is possible to completely delineate the tumor without surgical clips or postoperative hematoma (or both) obscuring the tumor margin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7490243

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  10 in total

1.  Preoperative chemotherapy for soft tissue sarcomas: reinventing the wheel.

Authors:  Gerald Rosen
Journal:  Skeletal Radiol       Date:  2008-07       Impact factor: 2.199

Review 2.  Preoperative therapy for extremity soft tissue sarcomas.

Authors:  Lara E Davis; Christopher W Ryan
Journal:  Curr Treat Options Oncol       Date:  2015-06

Review 3.  Preoperative radiotherapy for extremity soft tissue sarcoma; past, present and future perspectives on dose fractionation regimens and combined modality strategies.

Authors:  Rick L M Haas; Aisha B Miah; Cécile LePechoux; Thomas F DeLaney; Elizabeth H Baldini; Kaled Alektiar; Brian O'Sullivan
Journal:  Radiother Oncol       Date:  2015-12-21       Impact factor: 6.280

4.  A non-comparative phase II study of dose intensive chemotherapy with doxorubicin and ifosfamide followed by high dose ICE consolidation with PBSCT in non-resectable, high grade, adult type soft tissue sarcomas.

Authors:  Jörg Thomas Hartmann; M Horger; T Kluba; A Königsrainer; P de Zwart; C Hann von Weyhern; F Eckert; W Budach; C Bokemeyer
Journal:  Invest New Drugs       Date:  2013-10-04       Impact factor: 3.850

5.  Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates.

Authors:  Janelle M Meyer; Kelly S Perlewitz; James B Hayden; Yee-Cheen Doung; Arthur Y Hung; John T Vetto; Rodney F Pommier; Atiya Mansoor; Brooke R Beckett; Alina Tudorica; Motomi Mori; Megan L Holtorf; Aneela Afzal; William J Woodward; Eve T Rodler; Robin L Jones; Wei Huang; Christopher W Ryan
Journal:  Clin Cancer Res       Date:  2013-10-16       Impact factor: 12.531

Review 6.  Advances in neoadjuvant chemotherapy in soft tissue sarcomas.

Authors:  Alexandria Phan; Shreyaskumar Patel
Journal:  Curr Treat Options Oncol       Date:  2003-12

Review 7.  Optimizing radiation therapy and post-treatment function in the management of extremity soft tissue sarcoma.

Authors:  Thomas F DeLaney
Journal:  Curr Treat Options Oncol       Date:  2004-12

8.  Neoadjuvant chemoradiation therapy for soft tissue sarcomas of the extremities.

Authors:  Samuel Aguiar Junior; Fábio de Oliveira Ferreira; Benedito Mauro Rossi; Erika Maria Monteiro Santos; João Victor Salvajoli; Ademar Lopes
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

9.  Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience.

Authors:  Leyla Kılıç; Meltem Ekenel; Senem Karabulut; Fulya Ağaoğlu; Emin Darendeliler
Journal:  Contemp Oncol (Pozn)       Date:  2017-03-22

10.  Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response.

Authors:  Kripa Guram; Maria Nunez; John Einck; Loren K Mell; Ezra Cohen; P Dominick Sanders; Sayuri Miyauchi; Elizabeth Weihe; Razelle Kurzrock; Sarah Boles; Andrew B Sharabi
Journal:  Front Oncol       Date:  2018-10-17       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.